All Supplement articles
View all stories of the same content type.
-
SupplementA national audit of pancreatic enzyme replacement therapy (PERT) prescribing in patients with pancreatic cancer: The RICOCHET study
This supplement has been commissioned and funded by Viatris and developed in partnership with Guidelines.
NON-2021-4065 February 2022 -
Supplement
Improving patient outcomes: supporting pharmacists with the management of pancreatic exocrine insufficiency (PEI)
This supplement has been commissioned, funded, and reviewed by Viatris and developed in partnership with Guidelines for Pharmacy.
Information intended for UK healthcare professionals only.
NON-2021-6348 January 2022 -
Supplement
The importance of the progestogenic component of hormone replacement therapy in women with a uterus
Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.
